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Abstract Linking biological samples found at a crime
scene with the actual crime event represents the most
important aspect of forensic investigation, together with the
identification of the sample donor. While DNA profiling is
well established for donor identification, no reliable
methods exist for timing forensic samples. Here, we
provide for the first time a biochemical approach for
determining deposition time of human traces. Using
commercial enzyme-linked immunosorbent assays we
showed that the characteristic 24-h profiles of two circadian
hormones, melatonin (concentration peak at late night) and
cortisol (peak in the morning) can be reproduced from
small samples of whole blood and saliva. We further
demonstrated by analyzing small stains dried and stored
up to 4 weeks the in vitro stability of melatonin, whereas
for cortisol a statistically significant decay with storage
time was observed, although the hormone was still reliably
detectable in 4-week-old samples. Finally, we showed that
the total protein concentration, also assessed using a
commercial assay, can be used for normalization of
hormone signals in blood, but less so in saliva. Our data
thus demonstrate that estimating normalized concentrations
of melatonin and cortisol represents a prospective approach
for determining deposition time of biological trace samples,
at least from blood, with promising expectations for
forensic applications. In the broader context, our study
opens up a new field of circadian biomarkers for deposition
timing of forensic traces; future studies using other
circadian biomarkers may reveal if the time range offered
by the two hormones studied here can be specified more
exactly.
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Time estimation of a biological trace found at a crime scene
represents one of the most important aspects in forensic
casework, together with identification of the trace donor by
DNA profiling. Knowledge about trace timing allows
decisions to be made regarding whether the identified
donor could potentially be the perpetrator and may also
help to find potential eye witnesses or additional suspects.
In principle, time aspects of crime scene samples can be
seen from two sides. One side addresses the question of the
time interval a sample was present at the crime scene,
which may be addressable by differential degradation of
biomarkers, such as different kinds of RNAs, but more
detailed studies on this issue are needed [1]. The other side,
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which we address in this study, concentrates on determining
the time point (i.e. the time of day) a trace was deposited at
a crime scene, thereby bringing a chronobiological aspect
into forensic research.
The 24-h day–night rhythm has always been the most
reliable environmental cue for life on earth. Behavioural
characteristics, metabolism and body functions are ad-
justed constantly to changing light and dark periods [2].
One of the best studied biomarkers of the human
circadian pacemaker is the hormone melatonin, which
signals to the body the duration of the dark period [3].
Melatonin is only produced and secreted during the night
and shows its peak concentration in the later part of the
night [3]. Cortisol is also widely used as a biological marker
of circadian phase, often in parallel with melatonin [2, 4].
Cortisol levels display peak concentrations in the morning
shortly after wakening and decrease throughout the day and
night [5].
In this study, we investigated the feasibility of using
circadian hormones, such as melatonin and cortisol, for
estimating trace deposition time. We employed commer-
cially available enzyme-linked immunosorbent assays
(ELISA) easily applicable in forensic laboratories. To our
knowledge, this is the first study exemplifying that
deposition time of forensic traces can be estimated by
means of circadian biomarkers, although the use of
melatonin for time of death estimation has been described
before [6, 7].
Material and methods
Sample collections and preparations
All samples investigated in this study were collected during
an 8-week period in July to September 2009.
Samples for ELISA applicability testing
Three volunteers (two males, one female) under informed
consent provided blood and saliva samples collected at the
approximate peak and trough times of the two hormones of
interest (cortisol: two males, 7–8 a.m. and 11–12 p.m.;
melatonin: one male and one female, 3–4 a.m. and 3–4 p.m.).
Two blood samples were collected per time point (one for
serum preparation, one for sonication) by means of finger-
pricks using contact-activated lancets (Becton Dickinson B.V.,
Breda, the Netherlands), and one saliva sample per time point
was collected. Serum was obtained from coagulated blood
samples after centrifugation for 10 min at 15,000×g and 4°C.
Whole blood samples were briefly vortexed and centrifuged
before weak sonication (Amplitude 5, 2–3 pulses; Soniprep
150 plus, MSE, London, UK) to lyse the cells. Lysates and
0.5 ml aliquots of the saliva samples were centrifuged for
10 min at 15,000×g and 4°C. Supernatants were collected and
immediately used for Bradford assay (see below). The
remaining sample was stored at −20°C until assayed for
hormone content.
Samples for 24 h hormone profiling
Six volunteers (four females, two males, mean age±SD:
32±6 years) under informed consent provided blood and
saliva samples from seven time points throughout the day,
starting at 11 a.m. and subsequently every 4 h until 11 a.
m. the next day. For collection of the 11 p.m. and 3 a.m.
samples, only one dim light source was allowed to prevent
melatonin suppression. Approximately 1 ml of saliva and
40 μl of whole blood (via finger-prick) were collected. All
samples were kept at 4°C until the end of the sampling
period and processed immediately afterwards. Sample
volunteers were additionally asked to complete the
Munich Chronotype Questionnaire to assess individual
chronotypes before participating in the study to exclude
the possibility of incorporating extreme (and rare) chro-
notypes [8]. In addition, all sample donors reported intake
of either coffee or tea 1 day before and during the
sampling period, and half of the donors consumed nicotine
and/or alcohol. Blood and saliva samples were treated as
described above.
Dried and stored samples
A preliminary analysis was performed using blood samples
with stains dried overnight on cotton and parafilm. Results
were compared with samples deposited in tubes taken
simultaneously and kept at room temperature before
processing. To study the stability or degradation of
biomolecules, three volunteers under informed consent
provided blood and saliva samples at the approximate
melatonin peak time (collection in dim light), and two of
these subjects also provided samples within the approxi-
mate cortisol peak time. For melatonin analysis, seven
blood samples (30 μl each) and seven saliva samples
(140 μl each) were collected by each subject either on
parafilm (one subject) or cotton (two subjects). An
additional blood and saliva sample of the same volume
was collected into a 1.5 ml reaction tube as reference. For
cortisol analysis, seven blood samples (10 μl each) and
seven saliva samples (80 μl each) were collected by each
volunteer either on parafilm or cotton (one subject each),
with reference samples collected in reaction tubes. Samples
were kept at room temperature for 0, 1, 4, 7, 14, 21 and
28 days before storing at −80°C until processing. Tube
samples were frozen together with the dried T0 (time-point
0) samples. One cotton sample set for melatonin analysis
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was kept in the dark to control for light-dependent
melatonin degradation; all other sets were kept in natural
light conditions. Samples were kept on ice during prepara-
tion to reduce further degradation. Tube samples were
treated as described above, with the exception that the
blood tube samples were pre-diluted with ice-cold buffer
for sonication due to the small sample volume. Blood and
saliva stains were washed off from parafilm with an amount
of buffer equal to the volume of the corresponding (pre-
diluted) tube samples, and transferred into 1.5 ml reaction
tubes. Cotton stains were cut into small pieces and
transferred into 1.5 ml reaction tubes. The same amount
of buffer was added, and samples were vortexed for 40 s.
After brief centrifugation, the supernatants were collected.
To maximize the yield, the initial reaction tubes were
perforated at the bottom, and placed into the tubes
containing the respective supernatants. The piggyback
tubes were then placed into 50 ml reaction tubes and
centrifuged for 10 min at 2,300×g and 4°C. All samples
were assayed as described above, with the same final
sample dilutions as in the 24-h profiling.
Hormone assays
The commercially available ELISA kits employed in this
study are designed to measure either serum/plasma or
saliva/diluted serum, with the difference that the latter kits
are far more sensitive (analytical sensitivity according to
manufacturer: melatonin: 1.6 pg/ml for serum assay versus
0.3 pg/ml for saliva assay; cortisol: 2.5 ng/ml for serum
assay versus 0.3 ng/ml for saliva assay; for more informa-
tion on precision and accuracy, please refer to the respective
manuals [http://www.ibl-international.com]).
Cortisol assay
Two different cortisol ELISA kits were employed: one
designed for the determination of cortisol in human saliva
and diluted serum (Cortisol ELISA, RE 52611, IBL,
Hamburg, Germany) and the other one designed for the
determination of cortisol in human serum and plasma
(Cortisol ELISA, RE 52061, IBL, Hamburg, Germany).
Both assays were performed according to the manufac-
turer’s instructions. To test the comparability and sensitivity
of the assays, and to determine the optimal working
conditions, serum and whole blood samples were measured
with both ELISA kits in different dilutions, whereas saliva
samples were only tested with the saliva kit in different
dilutions. All dilutions were prepared with the zero-
standard supplied with the respective kit. All samples,
standards, and controls were assayed in duplicate and
measured at 450 nm in a plate reader (Varioskan Flash,
Thermo Scientific, Breda, the Netherlands).
Melatonin assay
Melatonin content in whole blood, serum, and saliva
samples was determined with a commercially available
ELISA kit (Non-Extraction Melatonin Saliva ELISA, IBL,
Hamburg, Germany). We refrained from testing the serum
kit (Melatonin ELISA, IBL, Hamburg) due to the large
sample volume needed for this assay. Serum and blood
samples (70 μl each) were diluted in ddH2O (double-distilled
water, to a final volume of 450 μl) and subjected to C18-
reversed phase columns (IBL, Hamburg, Germany) accord-
ing to the manufacturer’s instructions for melatonin extrac-
tion. Dried extracts were reconstituted in ddH2O and assayed
immediately in different dilutions per sample. All dilutions
were prepared with the zero-standard supplied with the kit.
All samples, standards, and controls were assayed in
duplicate and according to the manufacturer’s instructions.
Measurement wavelength was 450 nm (Varioskan Flash,
Thermo Scientific, Breda, the Netherlands).
Bradford assay for total protein
Total protein concentrations of serum, blood, and saliva
samples were determined using a commercially available
kit with bovine serum albumin as a standard (Coomassie
Protein Assay Kit, Pierce, Etten-Leur, the Netherlands) in a
microplate format, according to the manufacturer’s instruc-
tions. In order to be within the working range of the
standard protocol, 1 μl of blood and 5 μl of saliva samples
were diluted in 199 μl and 5 μl ammonium acetate buffer
(0.1 M, pH 6.8), respectively, containing protease and
phosphatase inhibitors (Halt™ Protease and Phosphatase
Inhibitor Cocktail, Pierce, Etten-Leur, Netherlands), further
on just referred to as ‘buffer’. Standards were prepared with
the same buffer; all samples and standards were measured
in duplicate (5 μl per well) at 595 nm (Varioskan Flash,
Thermo Scientific, Breda, Netherlands).
Statistical data analyses
Melatonin profiles were subjected to single-cosinor analysis
with a 24-h period for determination of rhythmicity [9]. All
other statistical analyses were performed with GraphPad
Prism 5 (GraphPad Software Inc., La Jolla, USA)
Results
ELISA applicability testing
First, samples (serum, blood and saliva) were tested with
a commercially available ELISA designed for determi-
nation of cortisol in human saliva and diluted serum
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samples. Optimal dilutions for serum and blood were
found to be 1:50, confirming the manufacturer’s infor-
mation on assay sensitivity for serum. For saliva, a 1:1
dilution was chosen.
Second, the same serum and blood samples were
subjected to a commercially available ELISA designed for
determination of cortisol in human serum and plasma
samples. Values obtained for serum and blood from the
two different ELISAs were strongly correlated (p<0.0001,
R2=0.9754; Electronic supplementary material, Fig. S1),
supporting the validity of our approach. Furthermore, due
to the higher sensitivity of the saliva assay, only 1 μl
instead of 20 μl of sample per well were needed to reliably
perform the assay. On average, cortisol concentrations
obtained from blood reached 67%±6% (mean ± SD) of
the corresponding serum concentrations using the 1:50
dilution.
Third, all three sample types were subjected to a
commercially available ELISA designed for determination
of melatonin in human saliva. Optimal dilutions were
determined as 1:10 for blood, and 1:1 for saliva. On
average, melatonin concentrations obtained from blood
reached 89%±3% (mean ± SD) of the corresponding serum
concentrations using the 1:10 dilution. Corresponding
values of the same individual and time point for saliva
and whole blood were significantly correlated for both
melatonin and cortisol (p=0.0001, R2=0.96 and p=0.0002,
R2=0.95, respectively; see Electronic supplementary material,
Fig. S2).
All further experiments were conducted using the
optimal working dilutions as stated above for both
melatonin and cortisol from saliva and whole blood
samples; for cortisol only the saliva ELISA was used in
the following because of its higher sensitivity.
Blood analyses
Total protein concentration in the 24-h serial blood samples
was measured to determine its potential use as a normal-
ization parameter in the circadian hormone analyses.
Remarkably stable total protein concentrations were
obtained both within and between subjects (Fig. 1), with
the mean value centred on 200 mg/ml. There were no
statistically significant inter-individual differences (one-
way ANOVA: p=0.2). From measuring hormone content
in the 24-h serial blood samples it became evident that all
subjects displayed a typical circadian cortisol profile, with
the characteristic concentration peak upon wakening ([10],
see ‘Reference’ in Fig. 2a), and also a typical circadian
melatonin profile with the characteristic concentration peak
during late night-time ([10], see ‘Reference’ in Fig. 3a).
These general patterns remained unchanged upon normal-
ization against total protein concentration (Figs. 2b and 3b).
In addition, all subjects displayed significant rhythms in
their respective melatonin profiles after cosine fitting.
A preliminary analysis of blood samples dried overnight
on porous (i.e. cotton) and non-porous (i.e. parafilm)
surfaces was performed and results were compared with
those from fresh samples taken simultaneously to obtain
information on the transferability of established protocols.
Total protein recovery from dried blood showed no
significant concentration difference to that obtained from
fresh blood (mean fresh blood: 216±56 mg/ml; mean dried
blood: 200±42 mg/ml). The same was found for cortisol
(mean fresh blood: 98.0±0.3 ng/ml; mean dried blood:
101.5±8.4 ng/ml) and melatonin (mean fresh blood: 39.0±
5.8 pg/ml; mean dried blood: 25.1±14.5 pg/ml).
For time-wise stability testing, blood stains on cotton
and parafilm of three individuals were kept at room
temperature for up to 28 days. Total protein concentrations
from aged blood samples of most individuals showed little
variation over the entire sample storage period (Fig. 4).
Only one individual sample set showed a statistically
significant decline with increased storage time (D2 in
Fig. 4), which caused a slight declining trend of the mean
signal. There were no statistically significant differences
between subjects (one-way ANOVA: p=0.17). Therefore,
total protein concentration can be used for normalization of
hormone signals in both fresh samples and aged trace
samples. Determination of cortisol (Fig. 5a) and melatonin
content (Fig. 5b) was possible for all dried blood samples
and time points. Correlation of absolute against normalized
hormone concentrations was highly significant for both
cortisol and melatonin (cortisol: Pearson’s r=0.8238, p=
0.0003; melatonin: Pearson’s r=0.7564, p=0.0001). Corti-
sol values obtained from both parafilm and cotton blood
stains at T0 (freshly dried) were almost identical to those
obtained from the respective reference tube samples of
freshly frozen blood (102 ng/ml versus 101 ng/ml, and
Fig. 1 Twenty-four-hour profiles of total protein concentrations in
blood samples from six individuals and the respective mean (±SD)
values
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64 ng/ml versus 68 ng/ml). However, both of the sample
sets analysed showed a statistically significant decline of
the cortisol signal with time, which was retained after
normalization (Fig. 5a). However, melatonin signals
obtained from cotton blood samples at T0 were lower
than those obtained from parafilm (parafilm: 81% of reference
tube; cotton: mean ± SD: 58%±7% of reference tube),
although values from the reference tube samples of freshly
frozen blood were similar between samples (mean ± SD:
53 pg/ml±11 pg/ml). Only one sample set showed a
significant decrease of melatonin with storage time (D2:
p=0.04), whereas the remaining two sample sets did not
(p>0.1; data not shown). After normalization of the
melatonin values, none of the sample sets showed a
statistically significant decline with sample deposition
time (Fig. 5b), and similar values were obtained for both
cotton sample sets independent of the light condition (see
D2 and D3, Fig. 5b).
Saliva analyses
Although in fresh saliva samples total protein concentration
was lower and more variable during the 24-h period
compared with blood samples, with highly significant
inter-individual differences (p=0.0006; Electronic supple-
mentary material, Fig. S3), the characteristic circadian
profiles could be generated for both cortisol and melatonin
(Electronic supplementary materials, Figs. S4 and S5). The
high saliva viscosity may have led to a higher background
noise in the melatonin assay (see S2 in Electronic
Fig. 4 Total protein concentrations obtained from five sets of dried
blood stains in six time intervals over a period of 4 weeks, and the
respective mean (±SD) values; statistically significant decay of
individual concentration values are indicated with *p<0.05; parafilm
samples: D1 and D4, cotton samples: D2, D3, and D5
Fig. 3 Twenty-four-hour profiles of melatonin concentrations in
blood samples from six subjects and the respective mean (±SD)
values; a reference curve (dark-gray solid line) shows the mean
melatonin values obtained from serum data described elsewhere [10];
statistically significant circadian rhythms are indicated (#p<0.1,
*p<0.05, **p<0.01)
Fig. 2 Twenty-four-hour profiles of cortisol concentrations in blood
samples from six individuals and the respective mean (±SD) values; a
reference curve (dark-gray solid line) shows the mean cortisol values
obtained from serum data described elsewhere [10]
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supplementary material, Fig. S5a). Due to the 24-
h variation in total protein concentration, normalization of
hormone patterns was less successful with saliva compared
to blood, which led to an occasional disappearance of the
typical night time melatonin peak in the normalized
analysis (see S1 in Electronic supplementary material,
Fig. S5b).
Determination of total protein concentration from dried
saliva stains revealed highly divergent results (data not
shown). Two of the sample sets showed a significant
decline of melatonin concentration with sample storage
time (D1: p=0.05, D3: p<0.0001), which was not observed
for the third set (Electronic supplementary material,
Fig. S6a). For cortisol, one of the two sets analysed showed
a significant decline of cortisol concentration with sample
storage time (D4: p=0.0012), whereas the other did not
(Electronic supplementary material, Fig. S6b).
Discussion
With this study, we demonstrate for the first time the
feasibility of estimating deposition time of biological traces
by means of circadian biomarkers. Our approach includes
determination of melatonin and cortisol concentrations and
their normalization against total protein concentration to
control for variation in sample input. This biochemical tool
is expected to enable a forensic researcher to narrow down
the time of deposition of a trace sample collected at a crime
scene to either late night (melatonin) or early morning
(cortisol). We chose a simple method based on ELISA
because (1) it allows the use of commercially available
assays that are fully established in clinical diagnostics
including quality control, (2) sample processing is straight-
forward and (3) only basic laboratory equipment is needed.
Alternatives for hormone quantifications include chromato-
graphic methods such as GC/MS or LC/MS. Studies of
human circadian rhythms aiming to establish biological
relationships normally involve strictly controlled laboratory
conditions (i.e. control of lighting levels, food intake,
posture, sleep etc.) for sampling, including also the so-
called constant routine protocol, which is used to unmask
endogenous rhythms from any confounding factors [4, 11,
12]. However, such controlled conditions were not applied
in our study aiming to provide a tool for future forensic
applications, and it is highly remarkable that we were still
able to reproduce both hormone profiles with high
accuracy. This provides encouraging evidence that our
approach can be transferred to forensic practice.
One key aspect of the ELISA assay applicability testing
was downscaling of the sample volumes necessary for the
assays to meet requirements of forensic trace analysis. With
the almost perfect correlation of the values obtained for the
same blood and serum samples using two different cortisol
ELISA kits, we were able to achieve this goal with only
1 μl of sample (instead of 20 μl) needed. In addition, in
order to use whole blood samples with the melatonin saliva
kit employed in this study, melatonin was extracted from
the samples to prevent matrix problems and false measure-
ments before applying the samples to the ELISA plate. This
extraction procedure has already been proven as feasible
approach using homogenized tissue of post-mortem human
pineal glands [6]. Overall, a total volume of 25 µl of blood,
corresponding to a cotton blood stain size of only 70 mm2,
is required to perform all melatonin, cortisol and total
protein measurements in duplicate. A minimal cotton blood
sample size of 50 mm2 would be required if single
measurements were employed. In contrast, a much higher
total volume of 160 μl saliva was needed for all measure-
ments in duplicates.
The highly significant correlations between corresponding
values for saliva and blood for both melatonin and cortisol
are in agreement with previously published data comparing
hormone concentrations between blood, serum, and saliva
[13–16]. The observation that cortisol concentrations
obtained from whole blood reached only 67% on average
when compared with the corresponding serum concentra-
Fig. 5 a Normalized cortisol concentrations obtained from two
individual sets of dried blood stains over a period of 4 weeks
including the respective linear regression lines fitting the data points;
statistically significant decay of individual concentration values are
indicated with *p<0.05, **p=0.002; b normalized melatonin concen-
trations obtained from three individual sets of dried blood stains over a
period of 4 weeks, including the respective linear regression lines
fitting the data points for set D1 and sets D2/D3; statistically
significant decay is indicated with *p<0.05
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tions may be explained by the dilution of the serum
component with the rest of the blood compounds present in
whole blood, leaving the same amount of cortisol in a larger
volume for the assay. However, this effect was not seen with
melatonin, where similar values from blood and serum were
obtained. It has been shown recently that melatonin is also
produced by immune cells present in the blood, providing a
melatonin pool that may not be accessible in serum alone
[17].
The 24 h profiling for total protein concentration and
hormone levels could be successfully performed for blood
samples. The finding of a remarkably stable total protein
concentration during the entire day–night period, both
within and between subjects, is in agreement with previous
data on serum and cellular blood components [18]. Hence,
these data allow the conclusion that normalization of
hormone levels against total protein levels can be consid-
ered a valid approach. Both melatonin and cortisol profiles
showed the typical 24 h pattern, with subjects who were
employed in different parts of this study (validation,
profiling, degradation) exhibiting high reproducibility
[4, 10–12, 19]. Comparison of our calculated mean
hormone patterns with the respective reference curves also
confirmed the previous statement that melatonin values in
blood reach similar levels to those in serum, whereas values
for cortisol are found to be lower [10].
Our preliminary blood stain analysis revealed a good
transferability of the methods established on fresh blood.
Surprisingly, the recovery rate of total protein and cortisol
came very close to the reference tubes from freshly frozen
samples, independent of the surface material. For melato-
nin, the recovery rate was lower (although not statistically
significant). As expected, resolubilisation of dried blood
was achieved more easily from non-porous surfaces. When
testing blood samples stored up to 4 weeks, total protein
concentrations were in general surprisingly stable across the
entire time period within and between individuals. As such,
we conclude that the use of this parameter for normalization
is a valid approach for forensic samples, at least within the
storage time limit of 4 weeks tested in our study. This
conclusion was strengthened by the highly significant
correlations found for measured against normalized values
for both hormones. In our hands, melatonin concentrations
from blood samples did not decrease significantly with
sample storage time of 4 weeks after normalization, which
is in line with previous data on post-mortem melatonin
degradation [7]. Interestingly, there was no remarkable
difference observed between the sample set kept in the dark
and the one kept near the window, suggesting that, at least
under these experimental conditions, photodegradation of
melatonin is negligible [20]. Although there is no report on
melatonin stability in stains thus far, it should be mentioned
here that melatonin is reported to be photolabile in solution
[20]. On the other hand, cortisol levels from blood declined
significantly with sample storage time, which is in contrast
to previous reports on the stability of cortisol in serum and
whole blood, yet to our knowledge there is no study on the
stability of cortisol in blood stains on cotton or parafilm in
the literature [21, 22]. Therefore, the observed time-wise
decay suggests that the use of this hormone may be difficult
in samples stored for longer time intervals. We would advise
the implementation of a strict threshold value for use and
interpretation of the result. In our albeit limited study, the
cotton sample set would be used as a reference and lead to a
threshold value of 2.5×10−7 (cortisol/protein normalized), or
7 days degradation time, below which no more conclusions
can be drawn on the sample deposition time. However, we
would like to emphasize that more detailed forensic
validation studies are needed to establish more stringent
regulations for this issue.
One interesting question raised by our study is whether
the same stain sample can be used for multiple purposes. To
test this, we used part of the melatonin extraction column
flow-through from two 20 µl fresh blood samples for DNA
extractions applying the QIAamp DNA Micro extraction
system (Qiagen), and were able to generate complete DNA
profiles with the AmpFlSTR Identifiler PCR amplification
kit (Applied Biosystems). In addition, by using another part
of the same flow-through it was possible to extract total
RNA after phenol extraction with the RNeasy Micro Kit
(Qiagen), to synthesise cDNA with the RevertAid H Minus
First Strand cDNA Synthesis Kit (Fermentas), and to
successfully perform mRNA profiling for blood specific
markers (data not shown) [23].
In general, the situation in saliva turned out to be more
difficult compared to whole blood, providing less consistent
and firm results. The large differences observed in total
protein concentrations within and between individuals
confirm previous findings, and do not allow recommending
this parameter for normalization [18, 24]. Also, the amount
of saliva needed for the assays might affect saliva usability in
forensic trace analysis. High-viscosity saliva resulted in
falsely increased melatonin values, and for some of the
subjects the peak in total protein concentration fell together
with the melatonin peak in the middle of the night,
cancelling out each other in normalization. It has been
described before that protein degradation in saliva is
extremely rapid compared to other biological fluids, and
starts immediately upon sample collection [25]. The dynamic
nature of the saliva proteome shows high variation in protein
concentration between and within individuals [18, 24]. Thus,
it remains to be shown if highly stable protein markers with
constant 24 h expression can be established. Until such
markers for normalization of variation in saliva input are
identified, the use of saliva in forensic applications of
circadian biomarkers is discouraged.
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It shall be mentioned that the use of the circadian
hormones melatonin and cortisol in future forensic appli-
cations is not without limitations. One aspect is that some
individuals represent extreme chronotypes (‘owls’ or
‘larks’; approximately 2% of the population, not part of
our study) with significantly shifted profiles in their
circadian rhythms. Furthermore, night-time melatonin bio-
synthesis is suppressible by exposure to light [3, 26, 27]. It
has been shown that a three hour night-time light exposure
(600 lux) decreased melatonin concentrations by 65%,
whereas cortisol levels were not significantly altered [28].
Furthermore, an association between reduced melatonin
levels with depression is reported in the literature but
discussed controversially [29, 30]. Cortisol, besides its role
as a circadian marker, is also known as biomarker for stress.
Although it is not immediately up-regulated in acute
(psychological) stress situations but instead exhibits a
delayed response, implying little or no influence on crime
scene samples [31, 32]. Yet, several human and animal
studies suggest associations between altered cortisol levels
and physical or mental symptoms, like posttraumatic stress
disorder or addiction (see [5, 33] and references therein).
Another aspect is that our approach is based on the fact that
every human being is entrained to the environment, mainly
by the synchronizing factor light. Yet there are a few
exceptions from this general principle, like blind persons
who have no conscious light perception and therefore may
show shifted circadian patterns [34]. Disturbed circadian
rhythms can also be found for some days after trans-
meridian flights (‘jet-lag’) and in shift workers with slowly
rotating schedules (see [35], and references therein).
Furthermore, reduced amplitudes in circadian rhythms,
including the melatonin rhythm, have been described in
the elderly, although this phenomenon needs to be studied
more systematically [36, 37]. Thus, data obtained for both
melatonin and cortisol in future forensic applications need
to be interpreted carefully and in the context of available
information on the case background.
Despite of the potential caveats listed we believe that the
presented approach based on the circadian hormones
melatonin and cortisol bears large potentials for a first
estimation of the time a biological trace was deposited at a
crime scene, which can provide crucial information for
solving crimes. Systematic studies in search for more
circadian biomarkers shall be carried out in the future to
see if the time range offered by the two hormones studied
here can be specified more exactly. In addition, our
approach may be transferable to forensic cases involving
whole bodies rather than traces: Pineal melatonin content
has been suggested as an additional indicator for estimating
time of death [7], yet confounding factors such as
depression/suicide have to be considered [38]. Also,
melatonin levels in different body sites were found to be
not significantly related to post-mortem interval or gender,
but highly correlated with each other [16]. Still, future
research is needed to confirm the feasibility of such an
approach. Besides the anticipated forensic application, there
may also be clinical applications for the described methods.
The small blood volume needed to perform the circadian
hormone analyses could be beneficial, for instance in the
monitoring of disturbed melatonin production and/or its
supplementation treatment in premature infants, or taking
advantage of the easily performed sampling via finger-
prick, which allows for multiple sampling even in children
or in elderly people in a domestic environment, a situation
often found in field studies on ageing or biological rhythm
disorders [39–42].
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